The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 15, 2010

Filed:

Oct. 16, 2003
Applicants:

Achim Feurer, Wilhelmsfeld, DE;

Samir Bennabi, Lyons, FR;

Heike Heckroth, Wuppertal, DE;

Hartmut Schirok, Wuppertal, DE;

Joachim Mittendorf, Wuppertal, DE;

Raimund Kast, Wuppertal, DE;

Johannes-peter Stasch, Solingen, DE;

Jean Mark Gnoth, Mettmann, DE;

Klaus Münter, Wülfrath, DE;

Dieter Lang, Velbert, DE;

Santiago Figueroa Perez, Leverkusen, DE;

Heimo Ehmke, Hamburg, DE;

Inventors:

Achim Feurer, Wilhelmsfeld, DE;

Samir Bennabi, Lyons, FR;

Heike Heckroth, Wuppertal, DE;

Hartmut Schirok, Wuppertal, DE;

Joachim Mittendorf, Wuppertal, DE;

Raimund Kast, Wuppertal, DE;

Johannes-Peter Stasch, Solingen, DE;

Jean Mark Gnoth, Mettmann, DE;

Klaus Münter, Wülfrath, DE;

Dieter Lang, Velbert, DE;

Santiago Figueroa Perez, Leverkusen, DE;

Heimo Ehmke, Hamburg, DE;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 43/90 (2006.01); A61K 31/519 (2006.01); A61K 31/505 (2006.01); C07D 487/00 (2006.01); C07D 239/02 (2006.01); C07D 401/00 (2006.01); C07D 403/00 (2006.01); C07D 405/00 (2006.01); C07D 409/00 (2006.01); C07D 411/00 (2006.01); C07D 413/00 (2006.01); C07D 417/00 (2006.01); C07D 419/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention relates to heteroaryloxy-substituted phenylaminopyrimidines, to methods for the production thereof, and to the use of the same for producing medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular diseases. The inventive compounds inhibit Rho-Kinase.


Find Patent Forward Citations

Loading…